Insider Trades - GLAXOSMITHKLINE PLC

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

GLAXOSMITHKLINE PLC: Declared Holdings
Company/Relationship	Reported	Shares	Ownership
ChemoCentryx, Inc. Beneficial Owner (10% or more) NasdaqGS:CCXI (historical quotes, profile, other insiders)	13-Feb-12	7,343,492	Indirect
Amicus Therapeutics, Inc. Beneficial Owner (10% or more) NasdaqGM:FOLD (historical quotes, profile, other insiders)	17-Jul-12	9,815,825	Indirect
Response Genetics, Inc. Beneficial Owner (10% or more) NasdaqCM:RGDX (historical quotes, profile, other insiders)	13-Sep-12	5,000,000	Indirect
Theravance, Inc. Beneficial Owner (10% or more) NasdaqGS:THRX (historical quotes, profile, other insiders)	30-Apr-13	26,721,193	Indirect

Insider & restricted shareholder transactions reported over the last two years
Date Shares Stock Transaction
30-Apr-13 *193,563 THRX Purchase at $34.61 per share.
(Cost of $6,699,215)
15-Feb-13 *116,527 THRX Purchase at $22.03 per share.
(Cost of $2,567,089)
2-Nov-12 *280,348 THRX Purchase at $22.35 per share.
(Cost of $6,265,777)
13-Sep-12 *5,000,000 RGDX Statement of Ownership
3-Aug-12 *316,334 THRX Purchase at $28.21 per share.
(Cost of $8,923,782)
17-Jul-12 *2,949,581 FOLD Purchase at $6.30 per share.
(Cost of $18,582,360)
16-May-12 *10,000,000 THRX Purchase at $21.29 per share.
(Cost of $212,900,000)
14-Feb-12 *88,468 THRX Purchase at $18.12 per share.
(Cost of $1,603,040)
13-Feb-12 *6,643,492 CCXI Acquisition (Non Open Market)
8-Feb-12 *700,000 CCXI Statement of Ownership
1-Nov-11 *58,411 THRX Purchase at $22.23 per share.
(Cost of $1,298,476)
2-Aug-11 *102,466 THRX Purchase at $19.71 per share.
(Cost of $2,019,604)
21-Jul-11 *9,401,499 THRX Acquisition (Non Open Market) at $0 per share.
* Indicates that some (or all) shares are held indirectly (e.g. in a trust, by a spouse, etc.)

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

Copyright © 2013 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.
Questions or Comments?

Insider & restricted shareholder transactions reported over the last two years
Date	Shares	Stock	Transaction
30-Apr-13	*193,563	THRX	Purchase at $34.61 per share. (Cost of $6,699,215)
15-Feb-13	*116,527	THRX	Purchase at $22.03 per share. (Cost of $2,567,089)
2-Nov-12	*280,348	THRX	Purchase at $22.35 per share. (Cost of $6,265,777)
13-Sep-12	*5,000,000	RGDX	Statement of Ownership
3-Aug-12	*316,334	THRX	Purchase at $28.21 per share. (Cost of $8,923,782)
17-Jul-12	*2,949,581	FOLD	Purchase at $6.30 per share. (Cost of $18,582,360)
16-May-12	*10,000,000	THRX	Purchase at $21.29 per share. (Cost of $212,900,000)
14-Feb-12	*88,468	THRX	Purchase at $18.12 per share. (Cost of $1,603,040)
13-Feb-12	*6,643,492	CCXI	Acquisition (Non Open Market)
8-Feb-12	*700,000	CCXI	Statement of Ownership
1-Nov-11	*58,411	THRX	Purchase at $22.23 per share. (Cost of $1,298,476)
2-Aug-11	*102,466	THRX	Purchase at $19.71 per share. (Cost of $2,019,604)
21-Jul-11	*9,401,499	THRX	Acquisition (Non Open Market) at $0 per share.